Wockhardt
WOCKPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Habil Khorakiwala · MD: Murtaza Khorakiwala · Listing date: Feb. 23, 2000 · Employees: 5000 · Mumbai · http://www.wockhardt.com

Stock Price vs Company Growth
1d
1.6%
1w
1.9%
1m
8.6%
3m
14.1%
6m
20.1%
1y
19.4%
5y
20.2%
10y
6.5%
all
9.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,575 1.6%
1,087
1,778
Company Overview

Sales
3,373 Cr
Growth: 4.5%
Profit after Tax
191 Cr
Growth: 768.2%
Mid Cap
25,598 Cr
P/E: 120.2x
Industry P/E: 30.3x
Fundamentals

Sales (Cr) ₹ 3,373
Growth 4.5%
EBITDA 19.3%
P/S 7.6x
Dividend 0.0%
P/E 120.2x
Book Value ₹ 304
PEG Ratio 27.0x
ROE 4.3%
P/B 5.2x
Shareholding Pattern

Institutions
Promoters
Themisto Trustee Company Private Limited
54.16 %
Themisto Trustee Company Private Limited
3.43 %
Pasithee Trustee Company Private Limited
3.07 %
Ananke Trustee Company Private Limited
2.89 %
Callirhoe Trustee Company Private Limited
2.89 %
Others
Jhunjhunwala Rakesh Radheshyam
2.26 %
Iepf
0.18 %
Increase    Decrease    No change
Company Profile Detailed

The company is a pharmaceutical and biotechnology company. The company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Businesses of the companyNew drug discoveryBranded pharmaceuticalsContract manufacturingBiologicals in diabetesVaccinesAPIAwards2009Outstanding National Citizen Award by National Citizens Guild.Strathmore’s Who’s Who - Social Entrepreneur of the Year.
Investors (117)
Followers (7)